RT Journal
A1 Pham-Kanter G, Alexander G, Nair K
T1 EFfect of physician payment disclosure laws on prescribing
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD May 28
VO 172
IS 10
SP 819
OP 821
DO 10.1001/archinternmed.2012.1210
UL http://dx.doi.org/10.1001/archinternmed.2012.1210
AB 
With the enactment of the Physician Payments Sunshine Provision of the Affordable Care Act, pharmaceutical manufacturers are now required to disclose certain payments made to physicians—for example, payments for consulting, honoraria, gifts, or travel.1 This law is based on the premise that transparency in these transactions is of public importance and that disclosure acts as a deterrent against quid pro quo exchanges; physicians may be reluctant to accept large payments if these payments are publicly known and perceived as compensation for prescribing certain therapies.2- 3